Caplight Directory>Companies>NeuCyte-preview>Neucyte


NeuCyte

NeuCyte

Private
Mountain View, CaliforniaN/Ahttps://www.neucyte.com/

Last Round

Grant

May 14, 2024

Total Funding Raised

$7.75M

Momentum Score

25 /100

Company Overview

NeuCyte is a biotechnology company that has developed a target-identification and drug-discovery platform designed to create medicines for the treatment of neurological disorders.

Keywords

iPSC-derived neural cellsCNS drug discoverydisease modelinginduced pluripotent stem cellsiPSCneurotoxicity assessmentin vitro modelsdisease in a dishpreclinical CROcompound screeningcell-based assaysSynFirestem cell modelsassay developmentphenotypic screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuCyte Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuCyte Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 14, 2024
GrantAug 14, 2023
Series AMay 8, 2018
View all Funding Rounds

NeuCyte Investors

Notable investors and investment history

InvestorRounds
Shenzhen Leaguer Tsing-Yuan Venture Capital ManagementSeries A
Co-Win VenturesSeries A
NIH RADxGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2025

    Monthly visitors increased 38% MoM, reaching 2.2K.

  • Dec 22, 2024

    Monthly visitors increased 70% MoM.

View all signals

NeuCyte Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuCyte Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuCyte's valuation, stock price, and market status.

Firmographic Details

HeadquartersMountain View, California
Employee Range10
Year Founded2015
Last FundingMay 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.